PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacogenomic Services for Older Adults: Seven Design Features From 11 Early Studies

pharmacogenomicspharmacogeneticsolder adultsgeriatricspolypharmacyscoping reviewimplementation scienceclinical decision supportmedication therapy managementCYP2D6CYP2C19pharmacist-led servicesCPIC Geriatrics / Geriatric Pharmacy

Background Information

Pharmacogenomics refines drug therapy for older adults through tailored service models.

Older adults face significant polypharmacy and pharmacokinetic changes, making individualized therapy crucial. The review identified 11 pharmacogenomic services with key design elements supporting precision therapeutics in older adults. The study offers a framework using pharmacogenomics within existing medication management to enhance therapeutic decisions in geriatric care. Pharmacogenomic services for older adults can integrate with current practices to refine drug therapy decisions.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Wehbe E, Patel TJ, Hughes S, Mostafa S, Kirkpatrick CM, Stocker SL

Citation: Wehbe E, Patel TJ, Hughes S, et al. Advancing Precision Therapeutics in Older Adults: A Scoping Review of Pharmacogenomic Service Models. Clinical pharmacology and therapeutics. 2026. doi:10.1002/cpt.70547

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.